Aging-related matrix metallopeptidase 10 and osteopontin levels are associated with pathology, cognitive decline and age at onset in Alzheimer’s disease
Preprint
Abstract
INTRODUCTION: Aging is the strongest risk factor for Alzheimer’s disease (AD) characterized by amyloid-β (Aβ) plaques and tau tangles in the brain. We aim to compare biological aging-related biomarkers among AD, non-neurodegenerative control (NDC) and non-AD neurodegenerative disease (Non-AD) individuals to evaluate their clinical utility. METHODS: We included 137 participants (37 NDC, 67 AD, 33 Non-AD) from the UCL Dementia Research Centre and measured matrix metallopeptidase 10 (MMP-10), osteopontin (OPN), neurofilament-light, and glial fibrillary acidic protein in cerebrospinal fluid (CSF) samples in addition to Aβ/pTau and clinical parameters. RESULTS: Elevated MMP-10 associated with poorer cognition and later onset specifically in AD, whereas elevated OPN associated with CSF Aβ and tau pathology. MMP-10 and OPN levels improved the differentiation of AD from NDC, and AD from Non-AD, respectively. DISCUSSION: Our study provides evidence on potential clinical utility of CSF MMP-10 and OPN in AD diagnosis and supports taking biological aging into consideration in AD research.Keywords
This publication has 40 references indexed in Scilit:
- CSF proteomics identifies early changes in autosomal dominant Alzheimer’s diseaseCell, 2024
- Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: An age‐continuous perspectiveAlzheimer's & Dementia, 2022
- CSF neurofilament light may predict progression from amnestic mild cognitive impairment to Alzheimer's disease dementiaNeurobiology of Aging, 2021
- Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumJAMA Neurology, 2021
- Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer’s disease and frontotemporal dementiaCell Reports, 2021
- Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approachJournal of Proteomics, 2018
- A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer’s modelsBrain, Behavior, and Immunity, 2018
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease ProgressionJAMA Neurology, 2016
- Novel Panel of Cerebrospinal Fluid Biomarkers for the Prediction of Progression to Alzheimer Dementia in Patients With Mild Cognitive ImpairmentArchives of Neurology, 2007
- Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microgliaGlia, 2007